01

Litifilimab Delivers Sustained Skin Clearance in Cutaneous Lupus Through 52 Weeks

Week 52 AMETHYST data show litifilimab lifted clear or almost clear erythema rates to 33.7% in crossover patients, with 75% reporting meaningful skin improvement.